4//SEC Filing
Keller Joseph Kenneth 4
Accession 0001209191-12-045117
CIK 0000831547other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 4:55 PM ET
Size
9.2 KB
Accession
0001209191-12-045117
Insider Transaction Report
Form 4
Keller Joseph Kenneth
EVP & Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2012-09-07+300,000→ 300,000 totalExercise: $12.01From: 2012-09-07Exp: 2022-09-07→ Common Stock (300,000 underlying) - Award
Common Stock, $0.001 par value
2012-09-07+20,000→ 28,000 total - Award
Common Stock, $0.001 par value
2012-09-07+100,000→ 128,000 total
Footnotes (3)
- [F1]50% of the restricted shares will vest on March 1, 2013 and the remaining 50% on September 1, 2013.
- [F2]25% of the restricted shares will vest on September 1, 2013 and an additional 25% on each anniversary therafter over three years.
- [F3]25% of the option shares shall vest on September 7, 2013. The remaining option shares shall vest thereafter in equal monthly amounts over three years.
Documents
Issuer
SPECTRUM PHARMACEUTICALS INC
CIK 0000831547
Entity typeother
Related Parties
1- filerCIK 0001557759
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 4:55 PM ET
- Size
- 9.2 KB